038290 Macrogen

Macrogen Launches 'Easybox', a Premium Temperature-Controlled Package

SEOUL, South Korea--(BUSINESS WIRE)--

The precision medicine biotechnology enterprise Macrogen (CEO Hyeon-yong Jeong, www.macrogen.com)(KOSDAQ:038290) announced today its new premium temperature-controlled packaging named ‘Easybox’ for customers in the gene and genome analytics service industry worldwide.

The customized premium temperature-controlled packaging option was developed by Macrogen, and its delivery speed and reliability were enhanced thanks to an express shipping service by FedEx Express (FedEx), the world’s largest express transportation company.

The Easybox, which includes gel packs, packing instructions and other supplies based on a customer’s specific shipment, enables customers to shorten their shipping preparation time. Macrogen’s Easybox is designed to minimize shipments’ temperature change throughout their transportation. In addition, customers will have the peace of mind that they can track their FedEx shipments over the entire journey.

To protect the content against external shock and maintain the temperature range, the customized delivery package is made of waterproof, insulated, and shock absorbing material. The packing instructions guide customers on how to pack their shipments using dry ice or gel packs to minimize temperature variation, keep delivery costs down and reduce the risk of accidents arising from poor management or overused dry ice or gel packs.

With the launch of Easybox service, Macrogen has made it more convenient for customers by reorganizing its delivery process management system for approximately 18,000 R&D customers in 150 countries. Macrogen plans on increasing its global sales of Easybox as sample management is becoming more vital for Macrogen’s customers, who are expanding from the biotechnology industry to a broader base of customers.

Macrogen CEO Hyeon-yong Jeong said, “As Macrogen’s customer base is expanding from researchers to clinical diagnosis and general customers, the sample management of customers is ever more complex.” He added, “The launch of this customized premium temperature-controlled packaging, Easybox will provide greater convenience for customers and manage customers’ samples safely”.

If you wish to find more details about Easybox, make an inquiry to Macrogen NGS Overseas Sales Division ([email protected]). More information can also be found at dna.macrogen.com.

EN
13/09/2016

Underlying

038290Macrogen

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Macrogen

 PRESS RELEASE
Free
038290 MACROGEN

Macrogen Licenses Gene Editing Technology from Broad Institute of MIT ...

SEOUL, South Korea--(BUSINESS WIRE)-- Macrogen, Inc. (CEO Ji-young Moon, www.macrogen.com) (KOSDAQ: 038290), a precision medicine biotechnology company, announced on April 5 that it has acquired a non-exclusive commercial research tool license to CRISPR-Cas9 technology from the Broad Institute of MIT and Harvard in the USA, and said that the company’s gene editing technical portfolio has been further strengthened by licensing of this technology. Macrogen has acquired around 50 technologies, including the CRISPR-Cas9 portfolio...

April 5, 2018 1 EN
 PRESS RELEASE
Free
038290 MACROGEN

Macrogen Corp.'s Clinical NGS Laboratory Receives CAP Accreditation

ROCKVILLE, Md.--(BUSINESS WIRE)-- Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. “Macrogen demonstrates leadership, innovation, and a passionate commitment to standards of excellence while providing the highest quality services, ultimately for patients,” said Bharati Jhav...

November 15, 2017 1 EN
 PRESS RELEASE
Free
038290 MACROGEN

Le laboratoire d’analyses NGS de Macrogen Corp. reçoit l’accré...

ROCKVILLE, Maryland--(BUSINESS WIRE)-- Macrogen Corp. (www.macrogenlab.com) annonce que son laboratoire d’analyses qui fournit des services cliniques NGS a été accrédité par le Comité d’accréditation du College of American Pathologists (CAP), suite aux résultats d’une récente inspection effectuée sur place dans le cadre des Programmes d’accréditation, du CAP. « Macrogen témoigne de son leadership, de ses innovations et de son engagement passionné à respecter les normes d’excellence tout en fournissant des services de q...

November 15, 2017 1 FR
 PRESS RELEASE
Free
038290 MACROGEN

Macrogen Established Its Branch in Spain, Strengthening Localization S...

SEOUL, South Korea--(BUSINESS WIRE)-- Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com) (KOSDAQ:038290), a precision medicine biotechnology company, announced on Sept. 4 that it will begin providing localization service in September at its branch in Madrid, Spain. The Spanish branch of Macrogen was established last December following its first European branch in Amsterdam, Netherlands. This branch will provide quick and customer-friendly services to Southern Europe and the MENA (Middle East and North Africa) area t...

September 4, 2017 1 EN
 PRESS RELEASE
Free
038290 MACROGEN

Macrogen a établi une succursale en Espagne, afin de renforcer son se...

SÉOUL, Corée du Sud--(BUSINESS WIRE)-- Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com) (KOSDAQ : 038290), une société de biotechnologie médicale de précision, a annoncé le 4 septembre que dès septembre elle offrirait, depuis sa succursale de Madrid en Espagne, un service de localisation. La succursale espagnole de Macrogen a été créée en décembre dernier après l’ouverture de sa première branche européenne à Amsterdam, aux Pays-Bas. Cette succursale fournira des services rapides et adaptés aux clients du sud de ...

September 4, 2017 1 FR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch